JP6034385B2 - 病原体を防除するためのアミノ酸配列 - Google Patents

病原体を防除するためのアミノ酸配列 Download PDF

Info

Publication number
JP6034385B2
JP6034385B2 JP2014532244A JP2014532244A JP6034385B2 JP 6034385 B2 JP6034385 B2 JP 6034385B2 JP 2014532244 A JP2014532244 A JP 2014532244A JP 2014532244 A JP2014532244 A JP 2014532244A JP 6034385 B2 JP6034385 B2 JP 6034385B2
Authority
JP
Japan
Prior art keywords
seq
peptide
group
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2014532244A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014533931A (ja
JP2014533931A5 (https=
Inventor
アルバ、ヤンネル アコスタ
アルバ、ヤンネル アコスタ
ガルシア、マリオ、パブロ エストラーダ
ガルシア、マリオ、パブロ エストラーダ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centro de Ingenieria Genetica y Biotecnologia CIGB
Original Assignee
Centro de Ingenieria Genetica y Biotecnologia CIGB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro de Ingenieria Genetica y Biotecnologia CIGB filed Critical Centro de Ingenieria Genetica y Biotecnologia CIGB
Publication of JP2014533931A publication Critical patent/JP2014533931A/ja
Publication of JP2014533931A5 publication Critical patent/JP2014533931A5/ja
Application granted granted Critical
Publication of JP6034385B2 publication Critical patent/JP6034385B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1706—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2014532244A 2011-09-30 2012-10-01 病原体を防除するためのアミノ酸配列 Active JP6034385B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CU2011-0181 2011-09-30
CU20110181A CU24076B1 (es) 2011-09-30 2011-09-30 Composición para el control de patógenos
PCT/CU2012/000005 WO2013044890A1 (es) 2011-09-30 2012-10-01 Secuencias de aminoácidos para el control de patógenos

Publications (3)

Publication Number Publication Date
JP2014533931A JP2014533931A (ja) 2014-12-18
JP2014533931A5 JP2014533931A5 (https=) 2015-06-18
JP6034385B2 true JP6034385B2 (ja) 2016-11-30

Family

ID=47143463

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014532244A Active JP6034385B2 (ja) 2011-09-30 2012-10-01 病原体を防除するためのアミノ酸配列

Country Status (16)

Country Link
US (1) US9549978B2 (https=)
EP (1) EP2767290B1 (https=)
JP (1) JP6034385B2 (https=)
KR (1) KR101986358B1 (https=)
CN (1) CN103874502B (https=)
AR (1) AR088176A1 (https=)
AU (1) AU2012315083B2 (https=)
BR (1) BR112014007491B1 (https=)
CA (1) CA2849040C (https=)
CL (1) CL2014000760A1 (https=)
CU (1) CU24076B1 (https=)
ES (1) ES2600903T3 (https=)
MX (1) MX348934B (https=)
RU (1) RU2636001C2 (https=)
WO (1) WO2013044890A1 (https=)
ZA (1) ZA201402171B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104262485B (zh) * 2014-04-15 2017-01-18 四川农业大学 罗非鱼sIgM截短重链恒定区蛋白多克隆抗体及其制备方法
CN105061575B (zh) * 2015-02-03 2020-08-04 浙江海洋学院 一种金枪鱼肝脏抗菌肽及其制备方法和用途
CN109350731A (zh) * 2018-12-18 2019-02-19 汕尾市维明生物科技股份有限公司 一种罗非鱼蛋白肽在制备免疫制剂中的应用
CN112979763A (zh) * 2021-03-03 2021-06-18 山东大学 一种基于可溶性疏水载体抗菌肽Oreoch-2的液相合成方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030056244A1 (en) * 2000-05-02 2003-03-20 Ning Huang Feed additive compositions and methods
US6753407B2 (en) * 2000-08-15 2004-06-22 North Carolina State University Antimicrobial peptides isolated from fish
WO2002014346A2 (en) * 2000-08-15 2002-02-21 North Carolina State University Antimicrobial peptides isolated from fish
CN1678632A (zh) * 2002-08-22 2005-10-05 加拿大国家研究所 一种从硬骨鱼中鉴定新的广谱抗菌肽的基因组途径
CN101111256B (zh) * 2004-12-15 2012-04-25 科罗拉多大学 抗菌肽及其使用方法
RU2302467C1 (ru) * 2005-12-01 2007-07-10 Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук Пептиды латарцины, проявляющие антимикробную активность
CA2645832A1 (en) * 2006-04-25 2007-11-01 Intercell Ag Hcv vaccinations
TWI299335B (en) 2006-12-05 2008-08-01 Academia Sinica Anti-microbal peptides and uses thereof
WO2009149554A1 (en) * 2008-06-11 2009-12-17 National Research Council Of Canada Antimicrobial components of the mucus and extruded slime of hagfish (myxine glutinosa)
CN102348723A (zh) * 2008-12-05 2012-02-08 安吉奥开米公司 肽治疗剂轭合物及其应用
US20100184684A1 (en) * 2009-01-06 2010-07-22 C3 Jian, Inc. Antibacterial and antifungal peptides
WO2010091294A2 (en) * 2009-02-05 2010-08-12 The Regents Of The University Of California New targeted antimicrobial moieties
CN101559214A (zh) * 2009-05-27 2009-10-21 珍奥集团股份有限公司 具有增强免疫功能作用的组合物及其用途
CN102021172A (zh) * 2010-06-23 2011-04-20 广西壮族自治区水产研究所 罗非鱼白细胞 cAMP 诱导早期抑制因子基因序列及用途
US9155800B2 (en) * 2011-01-07 2015-10-13 Valiant Biopharma Sdn Bhd Antimicrobial fusion compounds and uses thereof

Also Published As

Publication number Publication date
US9549978B2 (en) 2017-01-24
CN103874502B (zh) 2015-11-25
ZA201402171B (en) 2015-12-23
BR112014007491A2 (pt) 2017-04-04
MX2014003892A (es) 2014-07-09
CU24076B1 (es) 2015-01-29
AU2012315083B2 (en) 2016-02-25
EP2767290B1 (en) 2016-09-14
BR112014007491B1 (pt) 2022-03-03
CU20110181A7 (es) 2013-05-31
ES2600903T3 (es) 2017-02-13
JP2014533931A (ja) 2014-12-18
AU2012315083A1 (en) 2014-05-08
AR088176A1 (es) 2014-05-14
WO2013044890A1 (es) 2013-04-04
RU2014117659A (ru) 2015-11-10
CN103874502A (zh) 2014-06-18
KR20140070597A (ko) 2014-06-10
CA2849040A1 (en) 2013-04-04
KR101986358B1 (ko) 2019-06-05
MX348934B (es) 2017-07-03
US20140294871A1 (en) 2014-10-02
RU2636001C2 (ru) 2017-11-17
EP2767290A1 (en) 2014-08-20
CL2014000760A1 (es) 2014-08-22
CA2849040C (en) 2019-11-26

Similar Documents

Publication Publication Date Title
Bridle et al. Evidence of an antimicrobial-immunomodulatory role of Atlantic salmon cathelicidins during infection with Yersinia ruckeri
Zhou et al. A β-defensin gene of Trachinotus ovatus might be involved in the antimicrobial and antiviral immune response
Velázquez et al. Novel IFNγ homologue identified in Nile tilapia (Oreochromis niloticus) links with immune response in gills under different stimuli
Díaz-Rosales et al. The warm temperature acclimation protein (Wap65) has an important role in the inflammatory response of turbot (Scophthalmus maximus)
Liu et al. Characterization, evolution and functional analysis of the liver-expressed antimicrobial peptide 2 (LEAP-2) gene in miiuy croaker
JP2020109109A (ja) 新しいｃａｔｈ２誘導体。
Gan et al. Molecular and functional characterization of peptidoglycan-recognition protein SC2 (PGRP-SC2) from Nile tilapia (Oreochromis niloticus) involved in the immune response to Streptococcus agalactiae
Bae et al. Expression analysis and biological activity of moronecidin from rock bream, Oplegnathus fasciatus
Sathyamoorthi et al. Therapeutic cationic antimicrobial peptide (CAP) derived from fish aspartic proteinase Cathepsin D and its antimicrobial mechanism
JP6034385B2 (ja) 病原体を防除するためのアミノ酸配列
Liu et al. cDNA cloning and expression analysis of a hepcidin gene from yellow catfish Pelteobagrus fulvidraco (Siluriformes: Bagridae)
Liu et al. Molecular characterization and functional analysis of the hepcidin gene from roughskin sculpin (Trachidermus fasciatus)
Li et al. CsTNF1, a teleost tumor necrosis factor that promotes antibacterial and antiviral immune defense in a manner that depends on the conserved receptor binding site
JP2023103316A (ja) ＥＭＳ／ＡＨＰＮＤに対する防御効果を提供するＩｇＹ抗体含有餌料
Jiang et al. Recombinant expression of porcine lactoferrin peptide LF-6 with intein technology and its immunomodulatory function in ETEC K88-infected mice
Ma et al. Three novel Anas platyrhynchos avian β-defensins, upregulated by duck hepatitis virus, with antibacterial and antiviral activities
Wang et al. Molecular characterization, phylogenetic analysis and adjuvant effect of channel catfish interleukin-1βs against Streptococcus iniae
Wang et al. Molecular characteristics of interleukin (IL)-17A/F3 and its immune response on the pathogen and functional regulation on cytokines in common carp Cyprinus carpio L.
Huang et al. Characterization of the BPI-like gene from a subtracted cDNA library of large yellow croaker (Pseudosciaena crocea) and induced expression by formalin-inactivated Vibrio alginolyticus and Nocardia seriolae vaccine challenges
Ruan et al. The antibacterial activity of a novel NK-lysin homolog and its molecular characterization and expression in the striped catfish, Pangasianodon hypophthalmus
JP6921387B2 (ja) 抗微生物ポリペプチド
US12022851B2 (en) Bactericidal protein for control of Campylobacter and Listeria
Blumhardt Antimicrobial peptides: immunomodulatory and therapeutic potential for use in Atlantic salmon (Salmo salar)
Shen et al. Structure, biological properties and utilities of marine-derived antimicrobial peptides
Mu et al. Interferon-beta, interferon-gamma and their fusion interferon of Siberian tigers (Panthera tigris altaica) in China are involved in positive-feedback regulation of interferon production

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150423

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150423

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20160210

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160212

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160512

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160705

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20161004

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20161027

R150 Certificate of patent or registration of utility model

Ref document number: 6034385

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250